Seminar Friday, November 3, 2017

Peter Tolias, PhD
Professor and Interim Chair
Department of Biomedical Engineering, Chemistry and Biological Sciences
Director, Center for Healthcare Innovation
Stevens Institute of Technology

Innovation in Biomedical Engineering, Healthcare and Life Sciences at Stevens


The healthcare industry accounts for 18 percent of the nation’s gross domestic product (GDP), and continues to grow.  The Stevens Institute of Technology coordinates university efforts in this area, with over 70 faculty members and their students making significant scientific contributions to the pharmaceutical, biotechnology and medical device industries, clinical research organizations, medical centers, as well as to healthcare policy, delivery and management. The university’s interdisciplinary approach capitalizes on innovative developments in biology, chemistry, engineering, computer science, healthcare management, pharmaceutical manufacturing, business and ethics, and also leverage nano- and micro-scale technologies as enablers of transformative societal impact. Stevens biomedical engineering, life science research and educational programs are developing skills, technologies and processes that address major areas of emerging medical need in domains ranging from tissue engineering, drug discovery and development, biomaterials, biosensors and healthcare analytics, which continue to form an academic-industry-government enterprise striving to become a national leader in advancing translational biomedical developments. Current drug discovery and development activities include development of cancer drugs targeting the RAS and ERK signaling pathways and developing a therapeutic for traumatic lung injury.  Efforts in tissue engineering have advanced patient-specific 3D disease models for multiple myeloma, breast and prostate cancer, osteoporosis, and graft versus host disease.  These models are being used for drug development and therapy selection by industry and clinical partners.  Other tissue engineering activities include replacement of bone, skin, capillaries and peripheral nerves. Stevens is also actively developing surgical instruments, physiological sensors, remote monitoring and advanced data analytical tools and applying them to increase the efficiency of healthcare delivery and improve patient care.